
- 17:00 -18:00 UTC
- 12:00-13:00 ET (US & Canada)
- 19:00-20:00 CEST (Central Europe)
- 1:00-2:00 HKT (Singapore & Hong Kong)
Watch a preview from the webinar above!
Session Description:
This webinar will feature talks by Dr. Leo Nicolai and Dr. Adela Constantinescu-Bercu about recent updates on COVID and thrombosis moderated by Dr. Marta Brambilla.
Event Outline:
- Introduction by Marta Brambilla, Ph.D.
- COVID-19: A Thromboinflammatory Disease? by Leo Nicolai, M.D. (20 minutes)
- Thrombogenicity in Post-COVID Syndrome by Adela Constantinescu-Bercu, Ph.D. (20 minutes)
- Q&A with audience (15 minutes)
Supported by Werfen
Marta Brambilla, Ph.D.
Centro Cardiologico Monzino IRCCS
Milano, Lombardy
Italy
Leo Nicolai, M.D.
University Hospital LMU Munich
Munich, Germany
Adela Constantinescu-Bercu, Ph.D.
University College London
London, England
United Kingdom

- Introduction by Jad El Maamari, M.D.
- Should We Be Concerned That All Children Undergoing Surgery Will Develop a Thrombosis? An Overview of the Current Evidence by Julie Jaffray, M.D. (20 minutes)
- Developing a Surgical Thromboprophylaxis Algorithm for Surgical Patients: A Risk-Adapted Approach by Ketan Kulkarni, M.D. (20 minutes)
- Q&A with audience (15 minutes)
Watch a preview from the webinar above!
Session Description:
This webinar featured talks by Dr. Julie Jaffray and Dr. Ketan Kulkarni about thromboprophylaxis in surgery for teenagers moderated by Dr. Jad El Maamari.
Jad El Maamari, M.D.
BC Children's Hospital
Vancouver, British Columbia
Canada
Julie Jaffray, M.D.
Rady Children’s Hospital - San Diego
San Diego, California
United States
Ketan Kulkarni, M.D.
IWK Health Center
Halifax, Nova Scotia
Canada
- Describe cardinal features in the presentation of TTP
- Distinguish between TTP and other disorders of thrombocytopenia
- Identify appropriate clinical steps for patients with suspected TTP
Activity Title: A Hematologic Emergency: Would You Miss iTTP?
Topic: immune-mediated thrombotic thrombocytopenic purpura (aTTP/iTTP)
Accreditation Type: Physicians—Maximum of 1.0 AMA PRA Category 1 Credit(s)™
Nurses—1.0 contact hours of nursing continuing professional development credit
PAs—maximum of 1.0 AAPA Category 1 CME credits
Release Date: August 4, 2023
Expiration Date: August 3, 2024
Estimated Time to Complete Activity: 1.0 hour
METHOD OF PARTICIPATION/HOW TO RECEIVE CREDIT
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit fulfillment:
If you are requesting AMA credits, ANCC credits, or a certificate of participation, your certificate will be available for download.
Technical Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
Additionally, this site and its activities are best viewed using the latest operating system for your device.
TARGET AUDIENCE
This educational activity is intended for physicians and advanced practice professionals (APPs), including nurse practitioners and PAs who specialize in hematology, emergency medicine, critical care, nephrology, neurology, obstetrics, primary care, and other specialties who treat patients with hematologic emergencies.
This activity is designed to provide clinicians with education on how to recognize and diagnose iTTP and provide education on the management of acute episodes of iTTP, including the risk of relapse and strategies for multidisciplinary management with clinical colleagues.
DISCLAIMER
The France Foundation and ISTH present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, ISTH, and the commercial supporter(s) assume no liability for the information herein.
Spero Cataland, MD
Professor of Internal Medicine
Division of Hematology
Ohio State University
Columbus, OH
Nathan Nielsen, MD, MSc, FCCM
Associate Professor
Division of Pulmonary Critical Care and Sleep Medicine
University of New Mexico School of Medicine
Albuquerque, NM
Marie Ann Scully, MBE, BSc (Hons), MBBS, MRCP, FRCPath
Professor of Hemostasis and Thrombosis
Department of Hematology
University College London Hospitals
London, UK
- Understand the pharmacokinetic properties of DOACs
- Recognize how obesity and/or bariatric surgery may affect absorption and pharmacokinetics of DOACs
- Review existing evidence on safety and efficacy of DOACs in obesity and/or post bariatric surgery
Victoria Speed, PharmD
Kings College Hospital
Hassocks, England
United Kingdom
Andrea Van Beek, RN
Visalia Medical Clinic
Adventist Health Physicians Network
Visalia, California
United States
Julia Bayadinova, RN
St. Joseph's Healthcare Hamilton
Hamilton, Ontario
Canada
By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).
USER TERMS AND CONDITIONS | PRIVACY POLICY
Accept Terms & all Cookies
MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.
Performance Cookies
Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.
Google Analytics and Google Tag Manager embedded tracking functionalities are used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG's features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.